The overall goal is to understand the molecular events involved in the tissue-specific, regulated expression of the prolactin gene. The prolactin gene is regulated at the transcriptional level by a number of hormones including estradiol, epidermal growth factor, thyrotropin releasing hormone and dopamine. The proposed studied seek to examine the mechanisms which permit the multihormonal regulation of prolactin transcription. In particular attention will be focused on intracellular regulators of prolactin gene transcription, DNA sequences which are important for prolactin gene transcription and on DNA-binding factors which interact with these sequences.
The specific aims are approaches include: 1) The role of the catalytic subunit of the cAMP-dependent protein kinase in mediating cAMP effects on prolactin gene transcription will be examined by using a synthetic gene coding for the heat stable inhibitor of the kinase 2) Structural features of the estrogen response element of the rat prolactin gene which are necessary for binding the estradiol receptor and for stimulation of transcription will be examined through construction of synthetic estrogen response elements and mutagenesis of the response element 3) Features of the DNA binding domain of the estrogen receptor which are important for interaction with the prolactin estrogen response element will be explored through mutagenesis of the cloned receptor cDNA. 4) Linker scanning mutagenesis will be used to dissect the role of specific DNA sequences in the immediate 5' flanking region and an upstream enhancer/estrogen response element of the prolactin gene 5) DNA binding proteins which interact with specific prolactin gene sequences will be identified by mobility shift assay, purified by affinity chromatography and cDNAs cloned. These studies should provide increased understanding of the general mechanisms involved in the regulation of gene expression as well as the specific regulation of this physiologically important hormone.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK040339-03
Application #
3240540
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1988-09-20
Project End
1992-08-31
Budget Start
1990-09-01
Budget End
1992-08-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Howard, Paul W; Jue, Shall F; Maurer, Richard A (2009) Expression of the synaptotagmin I gene is enhanced by binding of the pituitary-specific transcription factor, POU1F1. Mol Endocrinol 23:1563-71
Kievit, Paul; Maurer, Richard A (2005) The pituitary-specific transcription factor, Pit-1, can direct changes in the chromatin structure of the prolactin promoter. Mol Endocrinol 19:138-47
Kievit, P; Lauten, J D; Maurer, R A (2001) Analysis of the role of the mitogen-activated protein kinase in mediating cyclic-adenosine 3',5'-monophosphate effects on prolactin promoter activity. Mol Endocrinol 15:614-24
Howard, P W; Maurer, R A (2001) A point mutation in the LIM domain of Lhx3 reduces activation of the glycoprotein hormone alpha-subunit promoter. J Biol Chem 276:19020-6
Howard, P W; Maurer, R A (2000) Identification of a conserved protein that interacts with specific LIM homeodomain transcription factors. J Biol Chem 275:13336-42
Wang, Y H; Jue, S F; Maurer, R A (2000) Thyrotropin-releasing hormone stimulates phosphorylation of the epidermal growth factor receptor in GH3 pituitary cells. Mol Endocrinol 14:1328-37
Wang, Y H; Maurer, R A (1999) A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter. Mol Endocrinol 13:1094-104
Nowakowski, B E; Okimura, Y; Maurer, R A (1997) Characterization of DNA regions mediating the ability of Ca2+/calmodulin dependent protein kinase II to stimulate prolactin promoter activity. Mol Cell Endocrinol 132:109-16
Liang, J; Moye-Rowley, S; Maurer, R A (1995) In vivo mutational analysis of the DNA binding domain of the tissue-specific transcription factor, Pit-1. J Biol Chem 270:25520-5
Howard, P W; Maurer, R A (1995) A composite Ets/Pit-1 binding site in the prolactin gene can mediate transcriptional responses to multiple signal transduction pathways. J Biol Chem 270:20930-6

Showing the most recent 10 out of 21 publications